---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-040675"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:24:58.306965+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Better Choice Q3 revenue rises 11% YoY to $13.1M; net loss improves 75%

## Summary
- Revenue of $13.1M, up 11% YoY and 24% from Q2 2023; 75% from Halo Holistic product line.
- Operating loss improved 59% YoY to $(2.6)M; operating margin improved 3,403 bps to (20%).
- Net loss improved 75% YoY to $(1.6)M; EPS improved 77% to ($0.05) per share.
- Adjusted EBITDA improved 95% YoY to $(0.1)M; Adjusted EBITDA margin improved 2,311 bps to (1%).
- Newly appointed CEO Kent Cunningham highlighted organic digital growth and cost improvements.

## SEC filing metadata
- accession: 0001493152-23-040675
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/0001493152-23-040675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-040675
- JSON: https://secwatch.observer/filing/0001493152-23-040675.json
- Plain text: https://secwatch.observer/filing/0001493152-23-040675.txt

## Key facts
- Earnings Releases
  SRx Health Solutions, Inc. reported nine months ended September 30, 2023 results: revenue $32.9 million, net income $(8.1) million, EPS ($0.26).
  - Period: nine months ended September 30, 2023
  - Revenue: $32.9 million
  - Net income: $(8.1) million
  - EPS: ($0.26)
  - Result: reported results
  source text: loss improved 46% YOY to $(8.1) million ● EPS improved 48% YOY to ($0.26) ● Adjusted EBITDA improved 47% YOY to $(3.8) million 1 ● Adjusted
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/0001493152-23-040675-index.htm
- Earnings Releases
  SRx Health Solutions, Inc. reported third quarter ended September 30, 2023 results: revenue $13.1 million, net income $(1.6) million, EPS ($0.05).
  - Period: third quarter ended September 30, 2023
  - Revenue: $13.1 million
  - Net income: $(1.6) million
  - EPS: ($0.05)
  - Result: reported results
  source text: Revenue increased 24% from second quarter 2023, and 11% year-over-year (“YOY”) to $13.1 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315223040675/0001493152-23-040675-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.